2-(trifluoromethyl)pyrimidine-5-carboxamide - CAS 1378340-42-1
Catalog: |
BB056995 |
Product Name: |
2-(trifluoromethyl)pyrimidine-5-carboxamide |
CAS: |
1378340-42-1 |
Synonyms: |
2-(trifluoromethyl)pyrimidine-5-carboxamide; S7J |
IUPAC Name: | 2-(trifluoromethyl)pyrimidine-5-carboxamide |
Molecular Weight: | 191.11 |
Molecular Formula: | C6H4N3OF3 |
Canonical SMILES: | C1=C(C=NC(=N1)C(F)(F)F)C(=O)N |
InChI: | InChI=1S/C6H4F3N3O/c7-6(8,9)5-11-1-3(2-12-5)4(10)13/h1-2H,(H2,10,13) |
InChI Key: | OKRNBFHZDGTDRX-UHFFFAOYSA-N |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021250531-A1 | 4-(4,5-dihydro-1h-pyrazol-1-yl)pyrimidine compound as cannabinoid receptor (cb1 receptor) antagonists and pharmaceutical composition including same | 20200608 |
WO-2021154902-A1 | Collagen 1 translation inhibitors and methods of use thereof | 20200130 |
KR-102006547-B1 | Benzamide derivatives compounds, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory disease as an active ingredient | 20171116 |
KR-20190056070-A | Benzamide derivatives compounds, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory disease as an active ingredient | 20171116 |
WO-2019098738-A1 | Benzamide derivative compound, method for preparing same, and pharmaceutical composition for treating or preventing inflammatory disease containing same as active ingredient | 20171116 |
WO-2015195922-A1 | Compounds for use in treating acute coronary syndrome and related conditions | 20140619 |
WO-2014062938-A1 | Rory modulators | 20121019 |
AU-2013326429-A1 | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
CA-2884922-A1 | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
KR-20150063152-A | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
Complexity: | 198 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 191.03064625 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 191.03064625 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 68.9Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
[29278-68-0]
1,4-Butanediol Terephthalate Dibenzyl Ester
-
[112157-39-8]
N2-[(Phenylmethoxy)carbonyl]-L-lysine tert-Butyl Ester
-
[868161-59-5]
(E,E)-5-[4-(Diethylamino)phenyl]penta-2,4-dienal
-
[1212679-29-2]
(3R,4R)-N-(3-Cyanophenyl)-3-[[4-[(4-fluorophenyl)methoxy]benzoyl]amino]hexahydro-4-hydroxy-1H-azepine-1-carboxamide
-
[1354469-76-3]
(3R,4R)-N,4-Dimethyl-piperidin-3-amine
-
(2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid
Customers Also Viewed
-
[144222-34-4]
(1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[14245-62-6]
Isopropyl ethanesulfonate
-
[2973-17-3]
N-Allylmaleimide
-
[51248-35-2]
4-Isobutyloxazolidine-2,5-dione
-
[1808-26-0]
Ethyl arachidonate
INDUSTRY LEADERS TRUST OUR PRODUCTS